Basic information Safety Related Supplier
ChemicalBook >  Product Catalog >  API >  Anesthetic Agents >  Local anesthetics >  Cinchocaine

Cinchocaine

Basic information Safety Related Supplier
Cinchocaine Basic information
Cinchocaine Chemical Properties
  • Melting point:64°
  • Boiling point:478.73°C (rough estimate)
  • Density 1.1145 (rough estimate)
  • refractive index 1.6300 (estimate)
  • pkapKa -5.3(aq. H2SO4) (Uncertain)
  • Water Solubility 68.01mg/L(temperature not stated)
  • CAS DataBase Reference85-79-0(CAS DataBase Reference)
  • NIST Chemistry ReferenceDibucaine(85-79-0)
Safety Information
Cinchocaine Usage And Synthesis
  • OriginatorCincain,Ophtha
  • UsesCinchocaine is a local anesthesic,used for Na+ channel blocker.
  • DefinitionChEBI: A monocarboxylic acid amide that is the 2-(diethylamino)ethyl amide of 2-butoxyquinoline-4-carboxylic acid. One of the most potent and toxic of the long-acting local anesthetics, its parenteral use was restricted to spinal anesthesia. It is now generally o ly used (usually as the hydrochloride) in creams and ointments and in suppositories for temporary relief of pain and itching associated with skin and anorectal conditions.
  • Manufacturing ProcessA benzene solution of 2.2 parts of α-chloro-γ-quinoline-carboxylic acid chloride is gradually mixed, while cooling, with 2.3 parts of unsymmetrical diethylethylenediamine. When the reaction is at an end the solution is washed with water and the new base extracted by means of hydrochloric acid. The base is precipitated by means of sodium carbonate and extracted with benzene. The solvent is distilled and the base recrystallized from petroleum ether. The α-chloro-γ-quinoline-carboxylic acid diethyl-amino-ethylene amide forms colorless lamina crystals of melting point 74°C. With acids the base forms neutral salts soluble in water.
    A solution of 2.5 parts of sodium in n-butylalcohol is boiled with 30 parts of α- chloro-γ-quinoline-carboxylic acid diethyl-amino-ethylene-amide in a reflux apparatus, and when the reaction is over the excess of butylalcohol is distilled. The remaining base is taken up with ether; the solution is washed with water and dried. The solvent is then distilled. The α-n-butoxy-γ-quinolinecarboxylic acid diethyl-amino-ethylene-amide forms as colorless crystals, after recrystallization from petroleum ether melting point of it 64°C.
    In practice it is usually used as hydrochloride.
  • brand nameNupercaine (Novartis).
  • Therapeutic FunctionLocal anesthetic
  • General DescriptionArticaine has a secondary nitrogen with a pKa of 7.8. It containsan aromatic thiophene ring bioisostere of the phenylring found in most other amide anesthetics. The log P of abenzene ring is 2.13 and the thiophene ring log P is 1.81,thus the thiophene ring is more hydrophilic than a phenylring. Although the thiophene ring has less lipid solubilitythan a phenyl ring, articaine is a lipid-soluble compound dueto the propylamine, the branched methyl and the substitutionson the thiophene ring. The onset of action of articaineis similar to lidocaine’s onset of action.
  • Contact allergensDibucaine hydrochloride is an amide group local anesthetic that can induce allergic contact dermatitis.
  • Clinical UseArticaine is availablein a 4% solution with epinephrine for use in infiltrationand nerve block anesthesia.Articaine is metabolized rapidly via plasma and tissuecarboxyesterase to its primary metabolite, the inactive,water-soluble carboxylic acid. Approximately 40% to 70%of articaine administered epidurally is metabolized to thecarboxylic acid, articainic acid. Approximately 4% to 15%of the articainic acid undergoes glucuronide conjugationand only 3% of the dose is recovered unchanged in theurine. The rapid plasma metabolism and reported inactivityof the carboxylic acid metabolite make articaine a potentiallysafer anesthetic agent when multiple or large dosesare necessary.
Cinchocaine Preparation Products And Raw materials
Cinchocaine(85-79-0)Related Product Information
CinchocaineSupplierMore
  • Company Name:Chongqing Landtower Pharmaceutical Co., Ltd. Gold
  • Tel:023-68980308
  • Email:business@cqlandtower.com
  •  
  • Company Name:Shandong Mingfeng Pharmaceutical and Technology Co. Ltd Gold
  • Tel:15315114555
  • Email:1345456643@qq.com
  •  
  • Company Name:3B Pharmachem (Wuhan) International Co.,Ltd.
  • Tel:18930552037 821-50328103-801
  • Email:3bsc@sina.com
  •  
  • Company Name:future industrial shanghai co., ltd
  • Tel:400-0066-400
  • Email:sales@jonln.com;sales@jonln.com
  •  
  • Company Name:Shanghai Hanhong Scientific Co.,Ltd.
  • Tel:021-54302127
  • Email:jerry.ma@hanhonggroup.com;jerry.ma@hanhonggroup.com;jerry.ma@hanhonggroup.com
  •